Your initial results may include increased feelings of hunger and less fatigue
A regulatory note for accuracy: neither BPC-157 nor TB-500 is approved by Health Canada for therapeutic use in humans, and both are listed on the World Anti-Doping Agency (WADA) Prohibited List BPC-157 under Section S0 (non-approved substances) and TB-500 under S2
Additionally, animal studies have administered BPC-157 for periods exceeding 14 days without observing any significant safety concerns or adverse effects [16]
In addition, they follow different logic after opening
Wollaston-Hayden EE, Harris RBS, Liu B, Bridger R, Xu Y, Wells L
Get a FREE 15-minute Virtual Protocol Review + our Regenerative Treatment Newsletter